About this trial
Clinical trials, specifically focused on anxiety disorder, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Eligibility criteria
Qualifiers
Aged ≥ 18 years old
Diagnosis of anxiety disorder
Able to comprehend the investigational nature of the protocol and provide informed consent
Disqualifiers
Female patients who are currently pregnant or nursing
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Inability to perform regular electronic reporting
Trial design
Treatments tested in this trial
- Not listed